Photo - EyeCheckup
play_arrow
View
57604

EyeCheckup

Turkey
Market: Medicine, Artificial Intelligence
Stage of the project: Operating business

Date of last change: 18.06.2022
Go to the owner's profile
2
equalizer from 2000
help
Calculated and estimated occupancy of the project (more about ratings)
My rating
1
2
3
4
5
6
7
8
9
10
Average rating:
 

Idea

Early diagnosis system for preventing vision loss using AI.

Current Status

Clinical trial on 900 patients completed successfully!
Pilot is running at Akdeniz University hospital.
Sponsorship and support by Canon, Bayer G4A, Topcon, Optomed.
4 Grants from Turkish Academy of Science, National Institutes of Health, Turkish Technology Development Foundation.
Total grants and investments over $820,000!
Amazon AWS AI Challenge Finalist!
Hello Tomorrow Global Pioneer Finalist!

Problem or Opportunity

90% of all vision loss cases can be prevented with early diagnosis. However most of the cases are still not prevented because eye exam is inconvenient or not affordable. Screening programs proved to be barely cost effective according to Deloitte analysis. Screening programs cover a small fraction of the population and omit all other diseases except one targeted disease. The rest of the population stays unscreened. Screened population still stays in the risk group a few years after the screening.
Eye diseases progress slowly and treatment is required a few years later.

Solution (product or service)

Artificial Intelligence in EyeCheckup analyses retinal diseases quickly and cost-effectively.
EyeCheckup is a permanent stationary solution used at Optometry, Community Centers, and primary care settings allowing annual screening of the entire population.
Citizens can check their retina for vision-threatening condition conveniently at any optics store. The Community Centers can increase their HEDIS score by providing eye screening services that are reimbursed by Medicare.
EyeCheckup has integrations with various EMR systems including VA VistA, Epic, and others.

Business model

SaaS subscription model will be used by Primary Care or Optometry covering the entire population.

Incubation/Acceleration programs accomplishment

Bayer G4A,
INTEMA AI Accelerator
ITU Cekirdek
5,00
1
2
3
4
5
1 voice
Sign in/Sign up
arrow_back
EN
more_horiz
close
visibility548
star0
Add to favorites
Delete from favorites
share
close
thumb_up1
Like
Unlike
Idea
Current Status
Market
Problem or Opportunity
Solution (product or service)
Competitors
Advantages or differentiators
Finance
Invested in previous rounds, $
Business model
Money will be spent on
Offer for investor
Team or Management
Mentors & Advisors
Lead investor
Risks
Incubation/Acceleration programs accomplishment
Won the competition and other awards
Invention/Patent
Product Video
Presentation